SWOG-9427, NCT00002921: S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery |
|
|
| Terminated | 2 | 13 | US | suramin, therapeutic hydrocortisone | Southwest Oncology Group, National Cancer Institute (NCI) | Adrenocortical Carcinoma | 01/04 | 01/04 | | |
NCT00621985: Dexamethasone Treatment of Congenital Adrenal Hyperplasia |
|
|
| Completed | 2 | 5 | US | dexamethasone, Decadron, Hydrocortisone | Boston Children's Hospital | Adrenal Hyperplasia, Congenital | 06/09 | 06/09 | | |
| Completed | 2 | 12 | Europe | Hydrocortisone intramuscular first, 100 mg hydrocortisone (Pfizer®) in 2 ml solvent, Hydrocortisone subcutaneously first | Bruno Allolio | Primary Adrenal Insufficiency | 07/12 | 07/12 | | |
NCT01064622: Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer |
|
|
| Completed | 2 | 118 | US | vismodegib, Erivedge, GDC-0449, Hedgehog antagonist GDC-0449, gemcitabine hydrochloride, dFdC, difluorodeoxycytidine hydrochloride, gemcitabine, Gemzar, hydrocortisone/placebo | National Cancer Institute (NCI) | Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer | 12/12 | 01/13 | | |
